Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/18146| Title: | The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration. | Austin Authors: | Trubiano, Jason ;Stone, Cosby A;Grayson, M Lindsay ;Urbancic, Karen F ;Slavin, Monica A;Thursky, Karin A;Phillips, Elizabeth J | Affiliation: | Infectious Diseases Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Centre for Improving Cancer Outcomes through Enhanced Infection Services, National Health and Medical Research Council Centre of Research Excellence, The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn Department of Medicine, University of Melbourne, Parkville, Victoria, Australia Pharmacy National Centre for Antimicrobial Stewardship, Royal Melbourne Hospital, Parkville, Victoria, Australia Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, WA, Australia Department of Medicine, Pathology, Microbiology, Immunology, Vanderbilt University Medical Center, Nashville, Tenn Department of Pharmacology, Vanderbilt University Medical School, Nashville, Tenn |
Issue Date: | 2017 | Date: | 2017-08-23 | Publication information: | The Journal of Allergy and Clinical Immunology. In Practice 2017; 5(6): 1532-1542 | Abstract: | Antibiotic allergy labeling is highly prevalent and negatively impacts patient outcomes and antibiotic appropriateness. Reducing the prevalence and burden of antibiotic allergies requires the engagement of key stakeholders such as allergists, immunologists, pharmacists, and infectious diseases physicians. To help address this burden of antibiotic allergy overlabeling, we review 3 key antibiotic allergy domains: (1) antibiotic allergy classification, (2) antibiotic cross-reactivity, and (3) multidisciplinary collaboration. We review the available evidence and research gaps of currently used adverse drug reaction classification systems, antibiotic allergy cross-reactivity, and current and future models of antibiotic allergy care. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/18146 | DOI: | 10.1016/j.jaip.2017.06.017 | ORCID: | Journal: | The Journal of Allergy and Clinical Immunology. In Practice | PubMed URL: | 28843343 | Type: | Journal Article | Subjects: | Antibiotic allergy Antimicrobial allergy Cephalosporin allergy Cross-reactivity Penicillin allergy Prevalence |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.